Search research articles
Contact Us
Filters
Showing results (111-120 of 169) with videos related to
Page
of 17
Sort By:
Oxidative Medicine and Cellular Longevity
|
March 21, 2022
Elucidating the Novel Mechanism of Ligustrazine in Preventing Postoperative Peritoneal Adhesion Formation
Lili Yang, Zhengjun Li, Yao Chen, et al.
European Journal of Medicinal Chemistry
|
July 1, 2021
Discovery of 2-(cyclopropanecarboxamido)-N-(5-((1-(4-fluorobenzyl)piperidin-4-yl)methoxy)pyridin-3-yl)isonicotinamide as a potent dual AChE/GSK3β inhibitor for the treatment of Alzheimer's disease: Significantly increasing the level of acetylcholine in the brain without affecting that in intestine
Xueyang Jiang, Chang Liu, Manxing Zou, et al.
Mini Reviews in Medicinal Chemistry
|
August 4, 2016
Recent Advances in the Discovery of HIF-1α-p300/CBP Inhibitors as Anti-Cancer Agents
Jinlian Wei, Yingrui Yang, Mengchen Lu, et al.
Journal of Medicinal Chemistry
|
November 22, 2025
Small Molecule-Drug Conjugates: An Emerging Drug Design Strategy for Targeted Therapeutics
Xiaolong Wang, Can Guo, Jikuan Shao, et al.
European Journal of Medicinal Chemistry
|
June 21, 2022
A highly effective and stable butyrylcholinesterase inhibitor with multi-faceted neuroprotection and cognition improvement
Qi Li, Baichen Xiong, Yuanyuan Wang, et al.
European Journal of Medicinal Chemistry
|
March 14, 2023
Therapeutic potential of targeting kynurenine pathway in neurodegenerative diseases
Hualiang Shen, Xinde Xu, Yalong Bai, et al.
Journal of Medicinal Chemistry
|
September 27, 2023
Identification of a Novel, Potent, and Orally Bioavailable Guanidine-Based SHP2 Allosteric Inhibitor from Virtual Screening and Rational Structural Optimization for the Treatment of KRAS Mutant Cancers
Qiangqiang Hou, Wenhua Jiang, Wenqiang Li, et al.
Journal of Medicinal Chemistry
|
May 11, 2021
Highly Potent and Selective Butyrylcholinesterase Inhibitors for Cognitive Improvement and Neuroprotection
Qi Li, Ying Chen, Shuaishuai Xing, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry
|
December 21, 2019
Design, synthesis, <i>in vitro</i> and <i>in vivo</i> evaluation of benzylpiperidine-linked 1,3-dimethylbenzimidazolinones as cholinesterase inhibitors against Alzheimer's disease
Jun Mo, Tingkai Chen, Hongyu Yang, et al.
Drug Development Research
|
June 16, 2025
Clinical Investigation of Tyrosinase Inhibitors: Past, Present, and Future
Yuanyuan Wang, Ruijia Jiang, Baichen Xiong, et al.
Page
of 17
Search research articles
Search
Showing results (111-120 of 169) with videos related to
Sort By:
Page
of 17
Oxidative Medicine and Cellular Longevity
|
March 21, 2022
Elucidating the Novel Mechanism of Ligustrazine in Preventing Postoperative Peritoneal Adhesion Formation
Lili Yang, Zhengjun Li, Yao Chen, et al.
European Journal of Medicinal Chemistry
|
July 1, 2021
Discovery of 2-(cyclopropanecarboxamido)-N-(5-((1-(4-fluorobenzyl)piperidin-4-yl)methoxy)pyridin-3-yl)isonicotinamide as a potent dual AChE/GSK3β inhibitor for the treatment of Alzheimer's disease: Significantly increasing the level of acetylcholine in the brain without affecting that in intestine
Xueyang Jiang, Chang Liu, Manxing Zou, et al.
Mini Reviews in Medicinal Chemistry
|
August 4, 2016
Recent Advances in the Discovery of HIF-1α-p300/CBP Inhibitors as Anti-Cancer Agents
Jinlian Wei, Yingrui Yang, Mengchen Lu, et al.
Journal of Medicinal Chemistry
|
November 22, 2025
Small Molecule-Drug Conjugates: An Emerging Drug Design Strategy for Targeted Therapeutics
Xiaolong Wang, Can Guo, Jikuan Shao, et al.
European Journal of Medicinal Chemistry
|
June 21, 2022
A highly effective and stable butyrylcholinesterase inhibitor with multi-faceted neuroprotection and cognition improvement
Qi Li, Baichen Xiong, Yuanyuan Wang, et al.
European Journal of Medicinal Chemistry
|
March 14, 2023
Therapeutic potential of targeting kynurenine pathway in neurodegenerative diseases
Hualiang Shen, Xinde Xu, Yalong Bai, et al.
Journal of Medicinal Chemistry
|
September 27, 2023
Identification of a Novel, Potent, and Orally Bioavailable Guanidine-Based SHP2 Allosteric Inhibitor from Virtual Screening and Rational Structural Optimization for the Treatment of KRAS Mutant Cancers
Qiangqiang Hou, Wenhua Jiang, Wenqiang Li, et al.
Journal of Medicinal Chemistry
|
May 11, 2021
Highly Potent and Selective Butyrylcholinesterase Inhibitors for Cognitive Improvement and Neuroprotection
Qi Li, Ying Chen, Shuaishuai Xing, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry
|
December 21, 2019
Design, synthesis, <i>in vitro</i> and <i>in vivo</i> evaluation of benzylpiperidine-linked 1,3-dimethylbenzimidazolinones as cholinesterase inhibitors against Alzheimer's disease
Jun Mo, Tingkai Chen, Hongyu Yang, et al.
Drug Development Research
|
June 16, 2025
Clinical Investigation of Tyrosinase Inhibitors: Past, Present, and Future
Yuanyuan Wang, Ruijia Jiang, Baichen Xiong, et al.
Page
of 17